High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma

Histone deacetylase 9 (HDAC9) is involved in a variety of malignant tumors, and leads to malignant tumor development and poor prognosis. However, the association between HDAC9 expression, and the prognosis and clinicopathological features of patients with pancreatic ductal adenocarcinoma (PDAC) rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, He, Li, Xiaocheng, Lin, Huapeng, Gong, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947911/
https://www.ncbi.nlm.nih.gov/pubmed/31974610
http://dx.doi.org/10.3892/mmr.2019.10869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947911/
https://www.ncbi.nlm.nih.gov/pubmed/31974610
http://dx.doi.org/10.3892/mmr.2019.10869

Ejemplares similares